Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Fruchart

Showing results (441-450 of 538) with videos related to

Pageof 54
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1993
Drug transfer across the blood-brain barrier: comparison of in vitro and in vivo modelsC Chesné, M P Dehouck, P Jolliet-Riant, et al.
Methods and Findings in Experimental and Clinical Pharmacology|April 1, 1985
Normolipemic activities of acrylophenone derivatives with antimicrotubular propertiesJ M Bard, M Luyckx, C Brunet, et al.
The Journal of Clinical Investigation|June 8, 2001
Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-IG Martin, H Duez, C Blanquart, et al.
The Journal of Biological Chemistry|February 5, 1993
Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg)A von Eckardstein, G Castro, I Wybranska, et al.
Clinical Chemistry|September 1, 1988
Enzyme-linked immunosorbent assay for serum amyloid A apolipoprotein with use of specific antibodies against synthetic peptidesR Saïle, C Delpierre, P Puchois, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
The role of a triplet repeat sequence of the very low density lipoprotein receptor gene in plasma lipid and lipoprotein level variability in humansN Helbecque, J Dallongeville, V Codron, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 4, 1998
VLDL compositional changes and plasma levels of triglycerides and high density lipoproteinF D Brites, C D Bonavita, M Cloës, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 23, 2000
Plasma cholesterol and endogenous cholesterol synthesis during refeeding in anorexia nervosaF Feillet, C Feillet-Coudray, J M Bard, et al.
Biochimica Et Biophysica Acta|June 2, 1994
Structural domain of apolipoprotein A-I involved in its interaction with cellsJ Luchoomun, N Theret, V Clavey, et al.
Biochimica Et Biophysica Acta|August 4, 1993
Tangier disease: isolation and characterization of LpA-I, LpA-II, LpA-I: A-II and LpA-IV particles from plasmaP Duchateau, D Rader, N Duverger, et al.
Pageof 54

Showing results (441-450 of 538) with videos related to

Sort By:
Pageof 54
Advances in Experimental Medicine and Biology|January 1, 1993
Drug transfer across the blood-brain barrier: comparison of in vitro and in vivo modelsC Chesné, M P Dehouck, P Jolliet-Riant, et al.
Methods and Findings in Experimental and Clinical Pharmacology|April 1, 1985
Normolipemic activities of acrylophenone derivatives with antimicrotubular propertiesJ M Bard, M Luyckx, C Brunet, et al.
The Journal of Clinical Investigation|June 8, 2001
Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-IG Martin, H Duez, C Blanquart, et al.
The Journal of Biological Chemistry|February 5, 1993
Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg)A von Eckardstein, G Castro, I Wybranska, et al.
Clinical Chemistry|September 1, 1988
Enzyme-linked immunosorbent assay for serum amyloid A apolipoprotein with use of specific antibodies against synthetic peptidesR Saïle, C Delpierre, P Puchois, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
The role of a triplet repeat sequence of the very low density lipoprotein receptor gene in plasma lipid and lipoprotein level variability in humansN Helbecque, J Dallongeville, V Codron, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 4, 1998
VLDL compositional changes and plasma levels of triglycerides and high density lipoproteinF D Brites, C D Bonavita, M Cloës, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 23, 2000
Plasma cholesterol and endogenous cholesterol synthesis during refeeding in anorexia nervosaF Feillet, C Feillet-Coudray, J M Bard, et al.
Biochimica Et Biophysica Acta|June 2, 1994
Structural domain of apolipoprotein A-I involved in its interaction with cellsJ Luchoomun, N Theret, V Clavey, et al.
Biochimica Et Biophysica Acta|August 4, 1993
Tangier disease: isolation and characterization of LpA-I, LpA-II, LpA-I: A-II and LpA-IV particles from plasmaP Duchateau, D Rader, N Duverger, et al.
Pageof 54